# Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele

> **NCT00175123** · PHASE4 · UNKNOWN · sponsor: **University of Aarhus** · enrollment: 30 (estimated)

## Conditions studied

- Myelomeningocele
- Bladder, Neurogenic

## Interventions

- **DRUG:** Botulinum A toxin

## Key facts

- **NCT ID:** NCT00175123
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** 2008-03
- **Final completion:** 2008-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00175123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00175123, "Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00175123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*